by S. Christian Platt | Sep 19, 2018 | PTAB News
By: Amanda Leckman and S. Christian Platt Patent Trial and Appeal Board (“PTAB”) hearings are typically open to the public, and a schedule of upcoming hearings is posted on the United States Patent and Trademark Office (“USPTO”) website. But hearings are only...
by Matthew Johnson | Aug 14, 2018 | Amendment Practice, PTAB News
By: Matt Johnson On Monday, the PTAB issued its fourth installment of its ongoing motion to amend study, providing details on motions to amend filed and decided through March 31, 2018. Patent owners have filed a motion to amend in 305 of the 3,203 completed trials...
by Matthew Johnson | Aug 10, 2018 | PTAB News, Uncategorized
By: Rich Graham and Matt Johnson The USPTO’s Patent Trial and Appeal Board (PTAB) has published an update to the AIA Trial Practice Guide (TPG) containing additional guidance about trial practice before the Board. The USPTO published the original TPG in August...
by S. Christian Platt | Aug 2, 2018 | PTAB News, PTAB Trial Basics
By: S. Christian Platt and Michael Lavine On July 26, 2018, the Silicon Valley Regional Office of the United States Patent and Trademark Office (“USPTO”) hosted a Judicial Conference by the Patent Trial and Appeal Board (“PTAB”). During the conference, a panel of...
by Gasper LaRosa | Jul 30, 2018 | PTAB News
By: Gasper J. LaRosa Last week, Chief Judge Ruschke made the attached presentation to the International Intellectual Property Association. Chief Judge Ruschke emphasized that IPR filings appear to be leveling off and that the PTAB does not invalidate patents at a...
by Marc S. Blackman | Jul 26, 2018 | Federal Circuit Appeal, PTAB News
By: Marc S. Blackman, Lisa L. Furby, and John Normile The Federal Circuit, in a matter of first impression, has ruled that tribal sovereign immunity does not apply to inter partes review (“IPR”) proceedings. Allergan, the maker of Restasis, a chronic...
